These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 1233383)
21. Platelet monoamine oxidase and clinical phenomenology of schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413 [TBL] [Abstract][Full Text] [Related]
22. Platelet monoamine oxidase activity in subgroups of alcoholics and controls: results from the Collaborative Study on the Genetics of Alcoholism. Anthenelli RM; Tipp J; Li TK; Magnes L; Schuckit MA; Rice J; Daw W; Nurnberger JI Alcohol Clin Exp Res; 1998 May; 22(3):598-604. PubMed ID: 9622437 [TBL] [Abstract][Full Text] [Related]
23. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
29. Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients. Propping P; Friedl W Psychopharmacology (Berl); 1979 Nov; 65(3):265-72. PubMed ID: 117498 [TBL] [Abstract][Full Text] [Related]
30. Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method. Sahai S; Arora RC; Meltzer HY Psychiatry Res; 1981 Oct; 5(2):111-4. PubMed ID: 6945605 [TBL] [Abstract][Full Text] [Related]
31. Platelet monoamine oxidase as a function of nongenetic factors. Friedhoff AJ; Miller JC Schizophr Bull; 1980; 6(2):314-9. PubMed ID: 6103576 [TBL] [Abstract][Full Text] [Related]
32. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [TBL] [Abstract][Full Text] [Related]
33. Influence of hemodialysis on monoamine oxidase kinetics in platelets from chronic schizophrenic patients. Wahlund LO; Smedby Y; Sääf J; Schulman A; Ross AB; Wetterberg L Artif Organs; 1983 Aug; 7(3):334-9. PubMed ID: 6625963 [TBL] [Abstract][Full Text] [Related]
34. Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1982 Oct; 7(2):179-87. PubMed ID: 6128754 [TBL] [Abstract][Full Text] [Related]
36. Parents of high risk subjects defined by levels of monoamine oxidase activity. Puchall LB; Coursey RD; Buchsbaum MS; Murphy DL Schizophr Bull; 1980; 6(2):338-46. PubMed ID: 7375867 [TBL] [Abstract][Full Text] [Related]
37. Platelet MAO activity in hallucinating and paranoid schizophrenics: a review and meta-analysis. Zureick JL; Meltzer HY Biol Psychiatry; 1988 May; 24(1):63-78. PubMed ID: 3285902 [TBL] [Abstract][Full Text] [Related]
38. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Rose RM; Castellani S; Boeringa JA; Malek-Ahmadi P; Lankford DA; Bessman JD; Fritz RR; Denney CB; Denney RM; Abell CW Psychiatry Res; 1986 Feb; 17(2):141-51. PubMed ID: 2870529 [TBL] [Abstract][Full Text] [Related]
39. Platelet monoamine oxidase activity in schizophrenia: relationship to family history of the illness and neuroleptic treatment. Maj M; Ariano MG; Pirozzi R; Salvati A; Kemali D J Psychiatr Res; 1984; 18(2):131-7. PubMed ID: 6747911 [TBL] [Abstract][Full Text] [Related]